narcolepsy with cataplexy: Narcolepsy with cataplexy is a sleep disorder characterized by excessive day-time sleepiness associated with uncontrollable sleep urges and cataplexy (loss of muscle tone often triggered by pleasant emotions).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
267 |
4. Check minimum number of eventsNone |
267 |
5. Include endpointsNone |
267 |
6. Filter based on genotype QC (FinnGen only) |
267 |
Control definitions (FinnGen only)
- Control exclude
- G6_EPIPAROX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G47
- Name in latin
- Narcolepsia
Similar endpoints
↥List of similar endpoints to
Narcolepsy and cataplexy
based on the number of shared cases.
Similar with more cases:
- Sleep disorders (combined)
- Episodal and paroxysmal disorders
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1805 | 929 | 870 |
| Only index persons | 1664 | 880 | 784 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 32.44 | 28.45 | 36.61 |
| Only index persons | 30.04 | 27.56 | 32.81 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 267 | 155 | 112 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | 35.72 | 31.84 | 41.09 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 226
- Matched controls
- 2261
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
+∞
274.6
204
*
N06BA07
ATC
modafinil; oral
701.7
96.0
88
*
G47.3
ICD-10 Finland
Sleep apnoea
70.9
87.4
98
24
214
Kela drug reimbursment
Severe and chronic narcolepsy
+∞
84.9
76
*
282
Kela drug reimbursment
Sodium oxybat
+∞
70.6
64
*
N06BA04
ATC
methylphenidate; oral
36.4
55.1
71
28
N07XX04
ATC
sodium oxybate; oral
+∞
42.0
39
*
TAB00
NOMESCO Finland
Lumbar puncture
21.6
40.1
60
37
G47.9
ICD-10 Finland
Sleep disorder, unspecified
42.5
31.8
39
11
G47.1
ICD-10 Finland
Disorders of excessive somnolence [hypersomnias]
+∞
29.9
28
*
R5140
NOMESCO Finland
Monitoring the use of the aid
23.3
27.2
39
20
N04BD01
ATC
selegiline; oral
101.8
25.3
27
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
10.3
23.1
47
56
N06AX16
ATC
venlafaxine; oral
5.9
21.0
65
145
3471A
ICD-9 Finland
Cataplexy and narcolepsy[NARCOLEPSIA]
+∞
20.1
19
*
R53
ICD-10 Finland
Malaise and fatigue
4.3
16.7
72
223
N06AA04
ATC
clomipramine; systemic
32.9
16.4
21
7
34700
ICD-8 Finland
Other disease of brain, Cataplexy and narcolepsy
+∞
15.8
15
*
N06AX18
ATC
reboxetine; oral
34.4
15.1
19
6
R06.5
ICD-10 Finland
Mouth breathing
8.4
14.0
31
42
3035
Kela drug reimbursment
NA
+∞
13.7
13
*
R40.0
ICD-10 Finland
Somnolence
49.5
12.0
14
*
E66.01
ICD-10 Finland
Obesity due to excess calories
6.5
11.9
31
54
WX722
NOMESCO Finland
PEEP
24.4
11.7
16
7
XG466
NOMESCO Finland
Sleep oxymetry
68.6
11.7
13
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
11.6
11
*
R03CA02
ATC
ephedrine; oral
126.2
11.5
12
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
7.8
11.4
26
37
Z01.8
ICD-10 Finland
Other specified special examinations
3.3
10.7
59
217
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.0
10.6
29
54
N04BC05
ATC
pramipexole; oral
6.7
10.4
26
43
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.5
9.9
50
171
R03AC02
ATC
salbutamol; inhalant
2.5
9.8
128
783
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.4
9.7
29
60
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
9.5
41
123
XA420
NOMESCO Finland
Extensive sleep examination
104.2
9.5
10
*
E66.8
ICD-10 Finland
Other obesity
11.4
8.9
16
15
N06AB04
ATC
citalopram; systemic
3.1
8.9
54
210
A02BA02
ATC
ranitidine; systemic
3.4
8.9
45
154
N03AX12
ATC
gabapentin; oral
3.7
8.9
39
119
XA800
NOMESCO Finland
Neuropsychological investigation
8.2
8.8
19
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
8.6
86
447
R51.80
ICD-10 Finland
Headache
3.5
8.6
42
140
N07XX11
ATC
pitolisant; oral
+∞
8.4
8
*
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
8.4
8
*
H02AB06
ATC
prednisolone; systemic
2.3
7.9
103
607
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
46.6
7.8
9
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
12.5
7.7
13
11
WX723
NOMESCO Finland
CPAP therapy
+∞
7.3
7
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
7.3
7
*
A02BC03
ATC
lansoprazole; oral
2.5
7.1
62
294
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
7.4
7.1
16
23
Z2445
NOMESCO Finland
Psychologist
5.5
7.1
20
39
J45.9
ICD-10 Finland
Asthma, unspecified
2.8
7.1
47
191
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
7.1
64
309
R55
ICD-10 Finland
Syncope and collapse
3.8
7.0
29
84
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
9.8
6.9
13
14
A46
ICD-10 Finland
Erysipelas
3.6
6.8
30
92
M03BX02
ATC
tizanidine; oral
2.1
6.8
126
850
R06.0
ICD-10 Finland
Dyspnoea
2.6
6.8
51
224
N03AX16
ATC
pregabalin; oral
2.7
6.7
50
217
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.8
6.5
14
19
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
7.8
6.5
14
19
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.9
6.5
20
44
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
71.8
6.5
7
*
N03AX09
ATC
lamotrigine; oral
5.8
6.4
17
31
E66.00
ICD-10 Finland
Metabolic syndrome
5.7
6.3
17
32
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
6.6
6.3
15
24
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
+∞
6.3
6
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
+∞
6.3
6
*
AA1AD
NOMESCO Finland
CT of head and brain
2.8
6.2
40
161
J45.1
ICD-10 Finland
Nonallergic asthma
4.4
6.2
21
51
N06AB03
ATC
fluoxetine; oral
3.2
6.2
32
112
N03AE01
ATC
clonazepam; systemic
5.5
6.2
17
33
G43.9
ICD-10 Finland
Migraine, unspecified
10.4
6.1
11
11
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
10.4
6.1
11
11
H02AB04
ATC
methylprednisolone; systemic
3.1
6.1
32
113
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
6.1
49
222
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.3
6.0
17
34
N02AA05
ATC
oxycodone; systemic
3.2
6.0
31
108
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044290) Cell count panel - Cerebral spinal fluid
40
23
20.28
49.89
1.2
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
9
22.60
13.54
1.3
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
8
23.99
13.08
1.1
1.5
—
—
—
0
0
(4027681)
14
13
11.31
12.96
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
16
9.18
11.21
1.1
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
16
9.18
11.21
1.1
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
133
786
2.38
10.91
4.9
6.0
mmol/l
1.2
1.2
0.36
107
672
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
121
692
2.37
10.63
4.6
5.1
mmol/l
1.2
1.2
0.00
107
640
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
20
7.33
9.38
1.1
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
20
6.78
8.14
1.1
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
137
895
2.09
8.02
5.4
5.7
umol/l
9.5
11.1
2.24
131
851
(3013826) Glucose [Moles/volume] in Serum or Plasma
152
1033
2.09
7.99
4.5
4.1
mmol/l
6.8
6.5
1.06
143
931
(3019309) Folate [Moles/volume] in Red Blood Cells
57
263
2.48
7.79
1.9
1.7
nmol/l
1360.5
1167.2
0.83
43
213
(3024561) Albumin [Mass/volume] in Serum or Plasma
111
678
2.09
7.71
5.0
4.3
g/l
36.8
36.6
0.18
106
648
(3019198) Lymphocytes [#/volume] in Blood
147
999
2.05
7.59
4.9
5.4
e9/l
1.9
2.0
0.48
136
898
(3001604) Monocytes [#/volume] in Blood
141
958
2.00
7.14
5.0
5.4
e9/l
0.5
0.6
0.41
128
841
(3006315) Basophils [#/volume] in Blood
141
962
1.99
7.01
5.0
5.4
e9/l
0.0
0.0
0.60
128
845
(3013115) Eosinophils [#/volume] in Blood
145
1002
1.98
6.92
5.2
5.8
e9/l
0.2
0.2
0.17
133
894
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
78
3.43
6.89
4.2
3.9
mmol/l
1.7
2.3
0.42
20
56
(1002224) Polysomnography panel
21
59
3.78
6.74
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
46
205
2.50
6.72
1.7
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
137
953
1.90
6.17
5.6
5.4
%
29.5
29.3
0.10
128
903
(3009508) Creatinine [Moles/volume] in Urine
88
528
1.99
6.17
3.4
3.0
mmol/l
7.5
8.1
0.48
71
447
(42870588) Differential panel, method unspecified - Blood
99
620
1.95
6.12
5.6
5.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
71
397
2.07
6.02
5.5
4.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
16
6.45
6.00
1.1
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
127
873
1.87
5.84
5.2
5.6
%
0.7
0.6
0.71
119
822
(3013650) Neutrophils [#/volume] in Blood by Automated count
155
1137
1.87
5.78
9.3
8.4
e9/l
4.1
4.1
0.01
136
992
(3018010) Neutrophils/100 leukocytes in Blood
134
942
1.85
5.70
5.4
5.2
%
56.5
56.5
0.02
126
894
(3012516) Albumin [Mass/volume] in Urine
72
414
2.01
5.62
4.0
3.2
mg/l
892.9
60.9
0.47
47
255
(3006504) Eosinophils/100 leukocytes in Blood
130
908
1.84
5.62
5.8
5.4
%
2.9
2.7
0.41
121
850
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
31
124
2.70
5.61
2.6
2.4
—
13.1
—
0
11
(3019069) Monocytes/100 leukocytes in Blood
130
911
1.83
5.54
6.5
5.6
%
8.1
8.3
0.47
122
865
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
42
196
2.36
5.53
9.7
4.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
76
448
1.97
5.52
5.1
3.8
mg/mmol
5.9
8.8
0.63
47
278
(3005719) IgG [Mass/volume] in Serum or Plasma
31
127
2.63
5.35
1.9
2.4
g/l
10.7
10.6
0.03
22
115
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
576
1.88
5.32
4.5
3.1
ng/l
19.5
45.1
2.06
56
339
(3000494) Fungus identified in Specimen by Culture
39
180
2.37
5.26
1.5
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
94
604
1.86
5.23
9.7
5.9
inr
1.1
1.2
0.71
26
208
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
66
377
2.00
5.22
3.6
2.8
ng/l
1119.1
1131.8
0.01
59
307
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
182
1430
1.86
5.19
7.9
6.5
u/l
76.3
77.4
0.13
173
1338
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
97
633
1.84
5.12
2.4
1.7
pmol/l
107.1
94.4
1.43
49
321
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
85
533
1.87
5.08
2.9
2.4
u/l
52.2
54.5
0.35
78
497
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
9
10.30
5.06
1.2
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
28
114
2.63
4.90
1.3
1.3
—
20.7
—
0
8
(3019225) pH of Specimen
31
134
2.49
4.81
2.8
4.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
68
404
1.92
4.76
1.9
1.6
mg/l
1.2
1.3
0.17
47
297
(3022313) Gas panel - Capillary blood
18
58
3.26
4.73
3.4
3.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
42
211
2.18
4.64
1.4
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
63
371
1.91
4.51
1.5
1.4
nmol/l
21.7
19.9
0.38
56
317
(3018418) pH of Serum or Plasma
75
468
1.84
4.49
4.2
3.2
ph
7.4
7.4
0.14
17
88
(3042936) Bacteria identified in Isolate by Culture
44
230
2.09
4.39
1.9
1.8
—
—
—
0
0
(3015736) pH of Urine
108
758
1.71
4.29
3.9
2.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
331
1.92
4.24
1.5
1.7
pmol/l
468.7
428.4
0.75
46
295
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
110
2.51
4.22
1.7
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
178
1435
1.72
4.16
4.4
3.5
mm/h
11.4
9.9
0.69
161
1327
(3037467) Urinalysis macro (dipstick) panel - Urine
169
1344
1.70
4.15
5.7
3.6
—
—
—
0
0
(3044889) 12 lead EKG panel
156
1215
1.68
4.14
3.7
3.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
42
3.46
4.10
2.4
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
128
951
1.66
4.04
3.8
2.6
ug/l
70.9
95.7
1.48
120
888
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
570
1.72
3.92
2.8
2.9
mmol/l
2.3
2.4
1.53
75
516
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
42
225
2.03
3.92
1.5
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
5
12.23
3.78
1.2
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
80
539
1.69
3.59
1.5
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
9
18
5.13
3.40
5.9
2.8
kpa
9.5
9.0
—
9
18
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
10
7.15
3.38
1.1
1.6
mmol/l
1.9
1.7
—
7
10
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
188
1580
1.64
3.35
4.2
3.7
pmol/l
14.4
14.6
0.76
176
1438
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
217
1897
1.77
3.29
4.7
3.6
mmol/l
5.9
5.7
1.86
198
1750
(3019150) Specific gravity of Urine by Refractometry
68
448
1.69
3.29
4.3
2.9
kg/l
1.0
1.0
0.22
11
56
(3035350) Ketones [Presence] in Urine by Test strip
125
961
1.57
3.21
4.5
2.9
estimate
0.0
0.0
0.00
24
186
(40761511) CBC panel - Blood by Automated count
249
2284
2.34
3.17
15.8
9.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
68
456
1.66
3.06
2.6
1.9
mg/l
2.8
2.8
0.01
55
387
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
163
2.02
3.05
1.4
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
525
1.63
3.04
1.4
1.3
u/ml
1.0
2.2
0.77
18
146
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
417
1.67
2.98
4.8
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
279
1.78
2.96
4.9
3.2
ng/l
94.3
166.5
0.50
28
192
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
165
1.99
2.96
1.5
1.6
—
—
—
0
0
(4146454)
6
9
6.79
2.88
3.7
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
45
275
1.77
2.82
1.4
2.5
ug/g
104.0
130.4
0.27
29
215
(3013290) Carbon dioxide [Partial pressure] in Blood
8
18
4.55
2.81
6.0
2.8
kpa
5.2
4.9
—
8
18
(3012544) pH of Venous blood
27
140
2.03
2.77
3.4
3.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.46
2.76
1.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
235
2137
1.83
2.67
16.8
10.0
mg/l
19.2
22.6
0.94
201
1569
(3029937) Albumin [Presence] in Urine by Test strip
73
514
1.58
2.67
4.7
3.1
estimate
0.0
0.0
0.00
24
179
(3002032) Base excess in Venous blood by calculation
26
136
2.01
2.61
3.4
3.1
mmol/l
2.0
1.9
0.01
18
99
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.25
2.56
1.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
102
781
1.50
2.53
2.6
2.2
nmol/l
73.4
75.0
0.26
95
708
(3009261) Glucose [Presence] in Urine by Test strip
123
978
1.48
2.53
4.6
3.0
estimate
0.0
0.0
0.00
24
176
(40758558) Short blood count panel - Blood
68
480
1.56
2.45
8.7
6.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
66
463
1.57
2.44
1.4
1.3
g/l
2.3
2.2
0.25
38
286
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
211
1879
1.59
2.43
14.3
9.5
ml/min/173m2
89.8
89.6
0.04
181
1491
(3021601) Nitrite [Presence] in Urine by Test strip
121
965
1.46
2.42
6.3
4.2
estimate
0.0
0.0
0.00
24
187
(4198724)
5
8
6.34
2.38
1.4
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
213
1907
1.58
2.34
5.3
4.2
mu/l
1.7
1.8
2.00
199
1760
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
23
3.55
2.29
1.4
2.6
nmol/l
22.6
25.1
—
8
23
(3010421) pH of Blood
8
23
3.55
2.29
6.0
2.8
ph
7.4
7.4
—
8
18
(4010399)
22
115
2.00
2.23
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
29
167
1.83
2.22
3.3
7.5
mmol/l
0.9
0.8
0.04
21
133
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
37
230
1.71
2.20
2.1
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
288
1.63
2.16
1.3
1.2
u/ml
23.6
13.1
0.26
17
118
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
132
1.90
2.12
1.4
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
20
3.56
2.07
1.6
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
251
1.65
2.04
1.4
1.4
titre
216.0
480.0
—
5
54
(3022145) Colonoscopy Study observation
33
203
1.71
2.04
1.2
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
71
2.18
1.96
1.2
2.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
85
2.07
1.95
4.0
6.3
mmol/l
24.6
24.7
0.07
17
85
(1175426) CD3 cells/100 lymphocytes in Blood
5
11
4.61
1.95
1.4
3.3
%
75.2
68.9
—
5
11
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
78
593
1.45
1.93
4.7
2.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
79
2.09
1.89
2.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
110
893
1.39
1.88
9.2
8.6
e9/l
0.0
0.0
0.50
91
740
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
161
1.75
1.87
1.7
2.4
u/l
6774.8
4607.8
—
7
70
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
96
763
1.40
1.85
4.7
3.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
12
4.22
1.83
1.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
35
2.62
1.82
1.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
219
1.63
1.79
3.6
2.2
%
25.7
25.2
0.07
28
195
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
30
2.72
1.74
1.0
1.2
—
120.7
—
0
6
(3026008) Bacteria identified in Urine by Culture
67
506
1.43
1.71
4.4
2.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
31
2.63
1.67
1.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
19
3.21
1.67
1.5
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
20
113
1.83
1.65
4.5
3.4
ng/l
83.1
71.2
0.29
14
102
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
41
283
1.53
1.63
2.4
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
14
3.62
1.62
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
112
931
1.35
1.60
5.8
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
293
0.55
1.59
1.2
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
20
3.04
1.59
3.5
2.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
55
406
1.45
1.58
4.0
2.5
umol/l
329.7
6442.0
1.77
46
364
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
33
2.47
1.55
1.0
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
33
2.47
1.55
1.0
1.1
—
—
—
0
0
(3013512) EKG study
60
457
1.40
1.45
4.8
3.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
31
207
1.56
1.43
5.5
3.3
%
35.1
32.1
0.66
19
133
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
42
301
1.47
1.41
1.3
1.2
iu/ml
9.5
29.6
2.34
14
97
(40761535) Cells panel - Urine sediment
20
120
1.72
1.38
5.6
2.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
42
2.18
1.35
1.4
3.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
83
1.86
1.34
3.9
7.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
190
1732
1.34
1.34
7.2
4.6
mmol/mol
40.1
38.5
1.27
175
1638
(3000475) Leukocytes [#/volume] in Synovial fluid
6
24
2.53
1.31
1.0
1.5
e6/l
15286.2
4740.3
—
6
18
(3000034) Microalbumin [Mass/volume] in Urine
6
24
2.53
1.31
2.5
3.1
mg/l
12.9
12.4
—
6
18
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
34
2.39
1.30
3.0
3.4
e9/l
3.7
4.4
—
8
34
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
34
2.39
1.30
3.0
3.4
%
53.5
58.0
—
8
34
(3016879) Cocaine [Presence] in Urine
25
163
1.59
1.28
1.5
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
172
1.57
1.26
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
108
1.71
1.26
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
63
1.95
1.25
1.1
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
45
2.03
1.24
2.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
49
2.08
1.23
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
19
2.66
1.22
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
28
191
1.52
1.20
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
222
2084
1.39
1.20
17.3
11.0
%
40.3
40.4
0.06
162
1681
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
50
2.04
1.18
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
244
0.59
1.16
1.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
39
2.08
1.16
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
20
2.53
1.15
1.4
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
20
2.53
1.15
1.6
2.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
159
1430
1.28
1.15
3.6
2.6
u/l
46.2
38.4
0.75
151
1355
(3002179) Metamyelocytes/100 leukocytes in Blood
21
135
1.60
1.15
6.3
3.6
—
0.4
—
0
29
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
65
1.89
1.15
1.2
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
58
1.94
1.14
1.5
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
138
0.49
1.13
1.6
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
164
0.53
1.12
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
28
196
1.48
1.07
4.0
2.6
umol/l
4.6
8.2
1.21
22
168
(3001019) Free T4 and TSH panel - Serum or Plasma
8
148
0.53
1.07
3.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
33
2.15
1.06
1.3
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
22
2.30
1.04
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
47
1.95
1.03
2.1
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
99
1.66
1.02
1.4
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
48
1.91
1.01
1.2
1.3
—
3.0
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
49
1.87
0.99
1.2
1.3
—
2.5
—
0
10
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
54
1.88
0.98
1.1
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
36
1.97
0.97
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
50
1.83
0.97
1.0
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
77
1.72
0.97
1.5
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
37
1.92
0.94
2.9
2.6
g/l
135.7
130.6
—
7
29
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
27
2.25
0.94
1.3
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
453
1.30
0.93
2.3
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
86
1.66
0.93
2.7
4.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
25
177
1.46
0.92
1.5
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
28
2.17
0.92
6.5
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
291
1.36
0.91
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
128
0.53
0.91
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
128
0.53
0.91
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
128
0.53
0.91
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
128
0.53
0.91
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
29
2.09
0.90
3.3
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
179
1.44
0.88
1.5
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
180
1.43
0.85
1.5
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
58
477
1.28
0.85
5.4
4.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
172
1.43
0.84
1.2
1.3
iu/ml
22.7
179.7
—
9
68
(3044640) Blood type and Crossmatch panel - Blood
70
591
1.25
0.83
4.8
2.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
32
1.89
0.82
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
68
573
1.25
0.82
3.7
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
23
166
1.42
0.78
1.7
2.4
u/l
31.8
30.8
0.07
18
148
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
24
2.10
0.75
1.8
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
106
0.56
0.74
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
106
0.56
0.74
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
109
0.54
0.74
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
74
637
1.22
0.73
5.6
3.2
e6/l
17.2
57.9
2.12
54
420
(3000991) Gas panel - Venous blood
19
134
1.45
0.73
5.0
7.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
449
1.25
0.73
2.4
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
56
1.63
0.73
1.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
25
2.02
0.73
1.2
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
18
126
1.46
0.72
1.9
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
178
1.38
0.72
1.5
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
93
1.53
0.71
3.8
3.3
ng/l
127.7
186.5
0.41
14
81
(3045424) Erythrocytes [Presence] in Urine
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
9
59
1.54
0.69
2.2
2.1
g/l
4.0
3.6
—
9
54
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
27
1.87
0.69
1.0
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
171
1.38
0.68
4.6
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
58
492
1.23
0.66
2.6
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
54
457
1.23
0.63
1.4
1.6
mmol/l
1.5
1.3
1.07
48
401
(3002582) Erythrocytes [#/volume] in Urine
60
516
1.21
0.60
4.6
2.8
e6/l
13.2
184.4
0.73
49
386
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
97
1.47
0.60
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
12
81
1.50
0.58
1.8
1.8
u/l
7.1
12.7
1.45
12
64
(40768804) Tissue Pathology biopsy report
85
758
1.18
0.58
2.0
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
55
473
1.21
0.56
4.4
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
108
1.41
0.54
3.5
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
179
1698
1.16
0.53
3.1
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
39
1.55
0.53
1.7
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
40
1.51
0.52
1.2
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
40
1.51
0.52
1.2
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
67
1.51
0.50
1.2
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
45
1.57
0.49
1.6
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
45
1.57
0.49
1.6
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
48
414
1.19
0.48
1.5
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
43
499
0.84
0.47
1.7
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
32
266
1.23
0.46
4.1
2.5
e6/l
0.4
1.2
3.00
17
155
(3049717) Cytology report of Urine Cyto stain
7
50
1.41
0.45
1.6
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
87
1.40
0.43
1.3
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
57
1.42
0.42
1.0
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.8
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
79
1.41
0.41
3.3
2.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
2.7
—
77.4
—
0
16
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
61
1.32
0.40
1.3
1.1
—
—
—
0
0
(4094501)
5
35
1.44
0.39
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
36
1.40
0.38
1.0
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
125
1.30
0.38
2.1
2.7
ml/min/173m2
62.9
77.1
—
8
59
(1761868) Lipid panel - Serum or Plasma
72
788
0.88
0.37
2.6
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
41
1.47
0.36
1.0
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
42
1.44
0.36
1.7
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
42
1.44
0.36
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
248
1.19
0.33
4.8
2.7
e6/l
0.8
3.0
2.47
14
138
(3000330) Specific gravity of Urine by Test strip
11
83
1.34
0.32
1.9
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
193
1.21
0.32
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
238
0.83
0.30
1.2
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
196
1904
1.11
0.29
4.3
3.2
mmol/l
1.4
1.2
1.61
173
1777
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
204
1988
1.11
0.27
4.6
3.4
mmol/l
1.4
1.5
1.87
183
1852
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
8
67
1.20
0.26
2.5
1.7
—
0.0
—
0
17
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
205
2001
1.11
0.25
4.8
3.5
mmol/l
4.5
4.6
1.48
189
1875
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
105
1.25
0.25
1.8
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
52
477
1.11
0.24
4.6
2.7
e6/l
0.2
0.4
1.95
41
349
(3025130) Human papilloma virus identified in Specimen
5
41
1.22
0.22
1.6
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
69
647
1.09
0.21
1.9
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
11
0.00
0.21
0.0
1.5
—
7.6
—
0
11
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020891) Body temperature
6
49
1.23
0.20
3.0
4.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
251
1.13
0.19
2.3
2.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
119
1.19
0.18
1.6
1.2
—
—
—
0
0
(4035726)
16
138
1.17
0.18
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
162
0.86
0.16
1.1
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
363
1.09
0.15
4.2
4.4
%
20.6
22.5
0.28
16
176
(3002256) Pathology report gross observation
26
240
1.09
0.11
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
167
0.89
0.11
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
135
0.88
0.10
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
205
2026
1.05
0.10
4.8
3.8
mmol/l
2.7
2.8
0.80
186
1883
(1761482) Bacteria [#/volume] in Urine by Culture
5
47
1.07
0.09
1.6
3.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
61
0.82
0.08
3.2
1.7
—
—
—
0
0
(4034850)
5
62
0.80
0.08
10.8
5.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
123
0.89
0.08
1.4
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
65
1.08
0.08
4.6
3.3
mg/l
1.5
1.3
—
7
58
(3003327) Ova and parasites identified in Stool by Light microscopy
8
75
1.07
0.07
1.1
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
104
0.86
0.06
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
100
1.10
0.05
2.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
120
1.09
0.05
1.6
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
71
698
1.02
0.03
1.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
179
0.95
0.03
4.1
2.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
92
1.09
0.03
1.0
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
10
93
1.08
0.02
4.5
9.2
%
94.8
94.8
—
10
93
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
267
1.01
0.00
3.4
3.0
ug/l
0.5
0.8
1.94
15
166
(3019832) Treponema pallidum Ab [Presence] in Serum
42
423
0.99
0.00
1.6
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
334
0.99
0.00
1.5
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
85
0.94
0.00
1.3
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
98
0.92
0.00
1.3
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
7.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
9.3
—
0
5
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
7.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.9
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
92
0.98
0.00
2.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
34.6
—
0
5
(44806420)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
8
0.00
0.00
0.0
9.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_NARCOCATA and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_NARCOCATA | 1.095 [0.82, 1.46] | 0.53 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 635 males with G6_NARCOCATA died.
Mortality risk
Mortality risk for people of age
years, who have G6_NARCOCATA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.215% |
| 5 | No data | 1.126% |
| 10 | No data | 2.798% |
| 15 | No data | 5.169% |
| 20 | No data | 9.036% |
Relationships between endpoints
↥Index endpoint: G6_NARCOCATA – Narcolepsy and cataplexy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data